Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Selective β-glucuronidase inhibitors as a treatment for side effects of camptothecin antineoplastic agents

Selective β-glucuronidase inhibitors as a treatment for side effects of camptothecin antineoplastic agents

US Patent 9334288 · Granted May 10, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibitors of microbial beta-glucuronidase enzymes and uses thereof2022
Phenoxy thiophene sulfonamides and their use as inhibitors of glucuronidase2017
Composition and method for inhibiting tumor cell growth2016
Method for sensitizing tumor cells to chemotherapeutic prodrug CPT-112015
Selective beta-glucuronidase inhibitors as a treatment for side effects of campt2013
Compositions and methods for inducing or inhibiting activities of selected human2012
Compositions and methods for inducing or inhibiting activities of selected human2011